Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07258069 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

Study acronym: HARMONY
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 7 to 6 Eligibility criteria expanded, about 11 words Show 1 more changeShow less
    • Eligibility criteria expanded, about 11 words
  2. Recruitment opened Trial sites expanded: 0 → 7 locations · Secondary endpoints revised (7) · Site contacts updated at 7 of 7 sitesv4 Show 3 more changesShow less
    • Trial sites expanded: 0 → 7 locations
    • Secondary endpoints revised (7)
    • Site contacts updated at 7 of 7 sites

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 7 · Start date changed from estimate of Feb 2026 to Apr 10, 2026v3 Show 2 more changesShow less
    • Study sites: 0 to 7
    • Start date changed from estimate of Feb 2026 to Apr 10, 2026
  4. Start date: Dec 2025 to Feb 2026v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Aesculap AG
32 trials monitored
See 6 trials at risk
The aim of the study is to proof the effectiveness of Histoacryl® on preventing recurrence or progression of subdural hematoma after embolization of the middle meningeal artery.
Trial Details
NCT Number NCT07258069
Lead Sponsor Aesculap AG
Conditions Subdural Hematoma, Subdural Hematoma, Chronic
Enrollment 178 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov